Matinas BioPharma Holdings Inc (MTNB) Short Interest Update
Matinas BioPharma Holdings Inc (NYSE:MTNB) saw a significant decrease in short interest in the month of October. As of October 13th, there was short interest totalling 2,032,088 shares, a decrease of 6.9% from the September 29th total of 2,182,518 shares. Currently, 2.8% of the shares of the company are short sold. Based on an average trading volume of 161,154 shares, the days-to-cover ratio is currently 12.6 days.
Matinas BioPharma Holdings (NYSE MTNB) opened at 1.14 on Wednesday. The firm has a 50-day moving average price of $1.29 and a 200-day moving average price of $1.89. The company’s market cap is $104.85 million. Matinas BioPharma Holdings has a 12-month low of $1.01 and a 12-month high of $3.99.
ILLEGAL ACTIVITY NOTICE: “Matinas BioPharma Holdings Inc (MTNB) Short Interest Update” was posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/10/25/matinas-biopharma-holdings-inc-mtnb-short-interest-update-3.html.
About Matinas BioPharma Holdings
Matinas BioPharma Holdings, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in identifying and developing therapeutics for the treatment of serious and life-threatening infections. It is engaged in developing a pipeline of product and development candidates, with an initial focus on serious fungal and bacterial infections.
Receive News & Ratings for Matinas BioPharma Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matinas BioPharma Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.